insights_auto
Why is ORX down 5.13%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEK 0.83
arrow_downward
-5.13%(-0.045) 1D
ኖቬም 16, 11:49:21 ጥዋት ጂ ኤም ቲ+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
291.26 ሚ
Avg. vol.
777.72 ሺ
Volume
205.53 ሺ
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13 ሚ
No. of employees
55
Open
SEK 0.89
High
SEK 0.89
Low
SEK 0.82
Mkt. cap
291.26 ሚ
Avg. vol.
777.72 ሺ
Volume
205.53 ሺ
P/E ratio
0.06
52-wk high
SEK 22.55
52-wk low
SEK 0.80
EPS
SEK 13.61
Shares outstanding
35.13 ሚ
No. of employees
55
News stories
From web sources and news partners
Business Insider
·
ከ40 ደቂቃዎች በፊት
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Reuters
·
ከ11 ደቂቃዎች በፊት
S&P 500, Nasdaq futures slide as Nvidia earnings, Anthropic debut loom
Benzinga
·
ከ57 ደቂቃዎች በፊት
Stock Market Today: Dow Jones, S&P 500 Futures Trade Mixed as Scott Bessent Presses Nvidia Over China Chi
Billionaires.Africa
·
ከ1 ሰዓት በፊት
American billionaire Elon Musk's SpaceX eyes S&P 500 entry through Tesla merger
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com